Member Info for TR64

Robin hood are beholding to the Sheriff of Nottingham ( Citadel) one of there biggest backers..

The Silly CEO got turned over last week by https://twitter.com/ChrisCuomo/status/1354994000294522881?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Etweet

DMP.

Clover have taken a view on GSK, but Dynavax Technologies were in a 3 way discovery venture with Clover GSK, I would say Dynavax Technologies have over committed themselves as they are already deep in another vaccine.

What as happened in the UK with AZN as caused other company's to stand back and consider how they could be effected.

GSK have been working with Medicago and Canada is hoping it comes to fruition.

VIR gave an update this morning which is revealing in itself , so we could see more news latter this week..

https://finance.yahoo.com/news/vir-biotechnology-announces-data-highlighting-130000630.html

Not looking for a pot of gold!!
Just focusing on the technology and themRNA is the route IMO, and with it comes more advances in Cancer treatments and autoimmune.

I dont subscribe to the Little Britain mentality that exists on these forums, is the long term science and discovery that is groundbreaking form BionTech and CVAC, plus the antibody treatments, as these will be able to help in many other long term disease processes .

GSK Sam mRNA will come to the forefront in time.

stelli,
I see now they have Novartis and Sanofi producing :)

Reading between various articles, countries ordering a variation of vaccines, does imply that this virus will need a annual vaccine and Pharma company's will having to keep adjusting the vaccines to variants that continue to appear.

Novartis as agreed to help BioNtech with production of its vaccine, combing EU countries manufacturing and Bayer helping to make more of CVAC vaccine

Thank you TA, that is most helpful and appreciated .

there is still the matter of GSK new technology, the "SAM mRNA" vaccine platform they have been working on since late 2019, is this being kept under wraps and used on the Canadian partner ?

Seaking 1

Do you have access to Investors Chronicle articles, I am just interested to know what the content is, and what it's based on.
https://www.investorschronicle.co.uk/news/2021/02/01/long-covid-why-gsk-may-have-played-a-better-vaccine-game-than-astrazeneca/

Emma is well respected in the San Fran Bay area of biotechnology, maybe worth looking at why they rate her so very high

Stille, I think I will leave the travel sector a bit longer, prepared to miss out on a rise.
Thanks for the link, CVAC spooked the market issuing 2.5% of new shares, a canny move by them, which was fully taken up @$90.00 I understand, maybe existing holders took them, which is limited to a few, as only 9% of stock is not held is held by others .

Oh Dear Flecyy, you seen to focus your attention on "Sanfio" and have missed the bigger picture, but the UK already have agreed a pre purchase along with the EU.

Never mind I'm sure you will find it of you look again .

Stille, it's hard to convince one self to put capital into NVAX, when the rise for less that $7.00 had already shot up to $160.00

How many missed CVAC Nasdaq last Thursday-Friday, I took up more at $84.00.
CVAC did a good job, going to market with a piddly 5 million shares @$90.00 discounting its closing price of $94.48 of Wednesday last week

IMO its still got $70.00 plus in it before it even announces the results of its mass trials of over 70,000 ppl

fleecy, I was putting specifics on AZN, not general UK investment in covid, perhaps they paid a lot for the French Vaccine.

My position on AZN is the UK as not matched the EU on like for like funding

Annuity payments to pay people pension, do not really allow for speculation on selling .

The separation of GlaxoSmithKline Consumer Health was a 3 year plan in 2019, it was hoped it would able to seprate the company Conusmer health in 2021, but a lot will depend on the Financial side, ands if it continues to bring in Revenue, then at this time, why hurry something into a market that is subdued due to the Pandemic.

The Dividend under threat by the Times is the usual BS crap the Times comes out with to suit the City fraudsters in London.

The CEO as delivered on all aspects to date, you can not get every new drug, treatment through, especially when they are not shown to be effective enough to take to commercialization, but the company will retain the rights and patents.

Like RC stated , 80p in based on GSK as a whole at this point.

Seems people like the Times forget how much GSK sold Horlicks for, realizing £3.4 billion .

If the Dividend was cut, then you will see an exit of Pension funds, as these help realize a annuity for pensions 5.85% dividend is a lot,.
Maybe the question should be how BP,cut the dividends instantly, despite sitting on Billion of Profits, that stinks, but that is Oil industry , a Industry that just pollutes the planet and causes disease

fleecy, the point being made is a simple one, all the capital invested under the EU, USA in vaccines drawfs anything the UK as put in.
AZN picked up £88 million for the UK government, in which part was for the vaccine, the UK as not invested in Sciences of Technology. The capital invested by the EU was even invested in AZN after The UK left the EU on 31 January 2020, even in a transition period it still invested 330 million Euros into AZN, it did not say Oh, the UK as left so we wont bother.

Warp speed payment of $1.2 billion was for the greater good of humanity.

The German Government invested 500 million in BioNtech since 2016, it invested 252 million Euros in CVAC in 2016 under a grant, it added to that in June July 2020 with a further 300 million Euros in CVAC though the KfW state bank .

The UK in my opinion plays politics at every opportunity, but that my opinion , which is differnt from your's but I back it up with facts on where the capital as come from

Stille, GSK as SAM mRNA Manufacturing.

Stille
Will a small, long-shot U.S. company end up producing the best coronavirus vaccine?
https://www.sciencemag.org/news/2020/11/will-small-long-shot-us-company-end-producing-best-coronavirus-vaccine

Stille
Might be of interests and to others in general, as the payment from Warp Speed is significant
https://www.sciencemag.org/news/2020/11/will-small-long-shot-us-company-end-producing-best-coronavirus-vaccine

AZN need to remember the fact that the EU injected 330 million euros in production of AZN vaccine, its not a simple matter of the EU wanting the AZN vaccine they ordered, however the contract reads by both parties.

If Biden decides the US Warp Speed payment of $1.2 billion to AZN/Oxford is an area of contention with the EU or USA not having equal share of the vaccine, then it will be dangerous, as AZN committed to equal distrubution of a vaccine.
I have no doubt the EU as Biontech production ramped up and Germany actaull funded Biontech from 2016 and paid for vaccines before the UK or others.

Time will tel.
One thing is for sure, all the good owrk done by Big Pharma during this pandemic to clean up itself, is now at risk with AZN debacle